INCR
InterCure Ltd.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · IL
$5.42
+3.04%Margins
Gross margin
15.1%
EBITDA margin
-20.5%
EBIT margin
-10.1%
Net margin
-13.2%
FCF margin
9.0%
-9.0%
Return on equity
-5.2%
Return on assets
-4.7%
Return on invested capital
0.39x
Asset turnover
$10.4M
Cash from operations
$1.03
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025